Literature DB >> 33627777

Smartphone-based symbol-digit modalities test reliably captures brain damage in multiple sclerosis.

Linh Pham1, Thomas Harris1, Mihael Varosanec1, Vanessa Morgan1, Peter Kosa1, Bibiana Bielekova2.   

Abstract

As the burden of neurodegenerative diseases increases, time-limited clinic encounters do not allow quantification of complex neurological functions. Patient-collected digital biomarkers may remedy this, if they provide reliable information. However, psychometric properties of digital tools remain largely un-assessed. We developed a smartphone adaptation of the cognitive test, the Symbol-Digit Modalities Test (SDMT) by randomizing the test's symbol-number codes and testing sequences. The smartphone SDMT showed comparable psychometric properties in 154 multiple sclerosis (MS) patients and 39 healthy volunteers (HV). E.g., smartphone SDMT achieved slightly higher correlations with cognitive subscores of neurological examinations and with brain injury measured by MRI (R2 = 0.75, Rho = 0.83, p < 0.0001) than traditional SDMT. Mathematical adjustment for motoric disability of the dominant hand, measured by another smartphone test, compensates for the disadvantage of touch-based test. Averaging granular home measurements of the digital biomarker also increases accuracy of identifying true neurological decline.

Entities:  

Year:  2021        PMID: 33627777     DOI: 10.1038/s41746-021-00401-y

Source DB:  PubMed          Journal:  NPJ Digit Med        ISSN: 2398-6352


  1 in total

Review 1.  Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis.

Authors:  S M Rao; A L Martin; R Huelin; E Wissinger; Z Khankhel; E Kim; K Fahrbach
Journal:  Mult Scler Int       Date:  2014-03-25
  1 in total
  10 in total

1.  A rapid assay provides on-site quantification of tetrahydrocannabinol in oral fluid.

Authors:  Hojeong Yu; Hoyeon Lee; Jiyong Cheong; Sang Won Woo; Juhyun Oh; Hyun-Kyung Oh; Jae-Hyun Lee; Hui Zheng; Cesar M Castro; Yeong-Eun Yoo; Min-Gon Kim; Jinwoo Cheon; Ralph Weissleder; Hakho Lee
Journal:  Sci Transl Med       Date:  2021-10-20       Impact factor: 19.319

Review 2.  Use of Mobile Applications to Increase Therapeutic Adherence in Adults: A Systematic Review.

Authors:  Eliana Alejandra Jiménez-Chala; Carlos Durantez-Fernández; José Luis Martín-Conty; Alicia Mohedano-Moriano; Francisco Martín-Rodríguez; Begoña Polonio-López
Journal:  J Med Syst       Date:  2022-10-22       Impact factor: 4.920

Review 3.  The potential use of digital health technologies in the African context: a systematic review of evidence from Ethiopia.

Authors:  Tsegahun Manyazewal; Yimtubezinash Woldeamanuel; Henry M Blumberg; Abebaw Fekadu; Vincent C Marconi
Journal:  NPJ Digit Med       Date:  2021-08-17

4.  Current Status and Future Opportunities in Modeling Clinical Characteristics of Multiple Sclerosis.

Authors:  Joshua Liu; Erin Kelly; Bibiana Bielekova
Journal:  Front Neurol       Date:  2022-05-27       Impact factor: 4.086

5.  Assessment of Smartphone-Based Spiral Tracing in Multiple Sclerosis Reveals Intra-Individual Reproducibility as a Major Determinant of the Clinical Utility of the Digital Test.

Authors:  Komi S Messan; Linh Pham; Thomas Harris; Yujin Kim; Vanessa Morgan; Peter Kosa; Bibiana Bielekova
Journal:  Front Med Technol       Date:  2022-02-01

Review 6.  Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Review of Clinical Manifestations as Foundations for Therapeutic Development.

Authors:  Spyros Papapetropoulos; Angela Pontius; Elizabeth Finger; Virginija Karrenbauer; David S Lynch; Matthew Brennan; Samantha Zappia; Wolfgang Koehler; Ludger Schoels; Stefanie N Hayer; Takuya Konno; Takeshi Ikeuchi; Troy Lund; Jennifer Orthmann-Murphy; Florian Eichler; Zbigniew K Wszolek
Journal:  Front Neurol       Date:  2022-02-03       Impact factor: 4.003

Review 7.  Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspective.

Authors:  Giacomo Lus; Marco André Bassano; Vincenzo Brescia Morra; Simona Bonavita; Antonio Gallo; Davide Maimone; Laura Malerba; Giorgia Teresa Maniscalco; Francesco Saccà; Giuseppe Salemi; Renato Turrini; Salvatore Cottone; Edoardo Sessa; Maria Buccafusca; Luigi Maria Edoardo Grimaldi
Journal:  Neurol Sci       Date:  2022-09-17       Impact factor: 3.830

Review 8.  Practice effects in performance outcome measures in patients living with neurologic disorders - A systematic review.

Authors:  Sven P Holm; Arnaud M Wolfer; Grégoire H S Pointeau; Florian Lipsmeier; Michael Lindemann
Journal:  Heliyon       Date:  2022-08-17

9.  Using Smartphones to Reduce Research Burden in a Neurodegenerative Population and Assessing Participant Adherence: A Randomized Clinical Trial and Two Observational Studies.

Authors:  Anna L Beukenhorst; Katherine M Burke; Zoe Scheier; Timothy M Miller; Sabrina Paganoni; Mackenzie Keegan; Ella Collins; Kathryn P Connaghan; Anna Tay; James Chan; James D Berry; Jukka-Pekka Onnela
Journal:  JMIR Mhealth Uhealth       Date:  2022-02-04       Impact factor: 4.773

10.  A smartphone sensor-based digital outcome assessment of multiple sclerosis.

Authors:  Xavier Montalban; Jennifer Graves; Luciana Midaglia; Patricia Mulero; Laura Julian; Michael Baker; Jan Schadrack; Christian Gossens; Marco Ganzetti; Alf Scotland; Florian Lipsmeier; Johan van Beek; Corrado Bernasconi; Shibeshih Belachew; Michael Lindemann; Stephen L Hauser
Journal:  Mult Scler       Date:  2021-07-14       Impact factor: 6.312

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.